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Whole‑genome sequencing‑based
phylogeny, antibiotic resistance, and invasive
phenotype of Escherichia coli strains colonizing
the cervix of women in preterm labor
Marvin Williams1, Alyssa B. Jones2, Amanda L. Maxedon1, Jennifer E. Tabakh3, Cindy B. McCloskey4,
David E. Bard5, Daniel P. Heruth2,6 and Susana Chavez‑Bueno2,3*

Abstract
Background: Escherichia coli is a major neonatal pathogen and the leading cause of early-onset sepsis in preterm
newborns. Maternal E. coli strains are transmitted to the newborn causing invasive neonatal disease. However, there is
a lack of data regarding the phenotypic and genotypic characterization of E. coli strains colonizing pregnant women
during labor.
Methods: This prospective study performed at the University of Oklahoma Medical Center (OUHSC) from March
2014 to December 2015, aimed to investigate the colonization rate, and the phylogeny, antibiotic resistance traits, and
invasive properties of E. coli strains colonizing the cervix of fifty pregnant women diagnosed with preterm labor (PTL).
Molecular analyses including bacterial whole-genome sequencing (WGS), were performed to examine phylogenetic
relationships among the colonizing strains and compare them with WGS data of representative invasive neonatal E.
coli isolates. Phenotypic and genotypic antibiotic resistance traits were investigated. The bacteria’s ability to invade
epithelial cells in vitro was determined.
Results: We recruited fifty women in PTL. Cervical samples yielded E. coli in 12 % (n=6). The mean gestational age
was 32.5 (SD±3.19) weeks. None delivered an infant with E. coli disease. Phenotypic and genotypic antibiotic resist‑
ance testing did not overall demonstrate extensive drug resistance traits among the cervical E. coli isolates, however,
one isolate was multi-drug resistant. The isolates belonged to five different phylogroups, and WGS analyses assigned
each to individual multi-locus sequence types. Single nucleotide polymorphism-based comparisons of cervical E. coli
strains with six representative neonatal E. coli bacteremia isolates demonstrated that only half of the cervical E. coli
isolates were phylogenetically related to these neonatal invasive strains. Moreover, WGS comparisons showed that
each cervical E. coli isolate had distinct genomic regions that were not shared with neonatal E. coli isolates. Cervical
and neonatal E. coli isolates that were most closely related at the phylogenetic level had similar invasion capacity into
intestinal epithelial cells. In contrast, phylogenetically dissimilar cervical E. coli strains were the least invasive among all
isolates.
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Conclusions: This pilot study showed that a minority of women in PTL were colonized in the cervix with E. coli, and
colonizing strains were not phylogenetically uniformly representative of E. coli strains that commonly cause invasive
disease in newborns. Larger studies are needed to determine the molecular characteristics of E. coli strains colonizing
pregnant women associated with an increased risk of neonatal septicemia.
Keywords: Escherichia coli, Preterm labor, Neonatal sepsis, Whole genome sequencing, Molecular phylogenetics,
Antibiotic resistance

Background
Escherichia coli has surpassed group B Streptococcus
(GBS) as the most common cause of early-onset sepsis
(EOS) in premature newborns. Traditional teaching has
held that GBS was responsible for EOS in term newborns; however, recent data demonstrates in selected
US areas E. coli is the most common pathogen associated with sepsis in term newborns [1]. Rates of E. coli
EOS continue to rise, particularly in preterm very-lowbirth-weight infants, increasing in this population from
10 cases per 1000 births twenty years ago to 14 cases per
1000 births in the last five years with associated mortality up to 40 % [2–4]. Maternal colonization with neonatal
pathogens is the primary risk factor for neonatal sepsis
[5]. This is well-established for GBS, which ascends from
the birth canal and infects the newborn causing septicemia [6]. GBS colonization rates, and the genomic characteristics of GBS strains that colonize pregnant women
are well described, but these data are lacking for E. coli
in pregnancy. Despite the limited characterization of the
strains colonizing pregnant women and their potential
pathogenic traits, E. coli transmission from mother to
newborn has been documented [7]. Animal models have
also demonstrated that vaginal colonization with E. coli
close to the time of delivery produces neonatal infection
[8]. It is therefore relevant to better understand the rate
of E. coli colonization in pregnant women, and the characteristics of these strains.
Previous research has demonstrated that E. coli is
a fecal colonizer in 100 % of pregnant women [9, 10].
However, the prevalence of E. coli in the genital tract of
pregnant women is not well-defined, particularly in the
United States. Moreover, unlike GBS, antibiotic resistance in invasive E. coli strains is widespread and has
progressively worsened [4]. As the incidence of invasive
neonatal E. coli continues to increase, it is essential to
understand the microbiologic characteristics of maternal
strains that newborns are closely exposed to during the
perinatal period. Only then can effective interventions be
created to optimize treatment approaches against neonatal sepsis.
The objectives of our pilot study were the following (1) Determine the E. coli cervical colonization rate
in women in preterm labor. We focused on women in

preterm labor because this diagnosis increases the risk of
delivering a preterm newborn with greater susceptibility
to infection [11]. (2) Characterize the strains’ phylogeny,
and phenotypic and genotypic antibiotic resistance characteristics. (3) Assess the invasive capacity of the recovered bacteria using an in vitro epithelial cell invasion
model.

Results
Subjects’ clinical characteristics and pregnancy outcomes

We identified 50 women in preterm labor (PTL) who
met the criteria for study participation from March 2014
through December 2015. The demographic and clinical
characteristics of the subjects are shown in Table 1.
Cervical colonization of E. coli was present in six
women, for a prevalence of 12 % (95 % CI 2.99-21.01).
There was no statistical significance in race distribution,
maternal chronological age, gestational age at which
the cervical sample was collected upon enrollment, and
length of stay between women colonized with E. coli
compared to noncolonized women. The rate of delivery
in both groups was similar. No study participant had a
history of urinary tract infection within a month before
sample collection or reported a history of fever within
the week preceding enrollment in the study.
Compared with non-colonized versus colonized
women, rupture of membranes and placental histopathologic chorioamnionitis occurred only in the noncolonized group. No cases of clinical chorioamnionitis
were diagnosed. The presence of chorioamnionitis was
unknown in four women, all without E. coli cervical
colonization. Both groups had similar rates of bacterial
vaginosis and concurrent GBS colonization. Twentyseven women were delivered before discharge. Pathology
examination was performed in 16 of the 27 delivered placentas; none of these mothers were colonized by E. coli.
Median gestational age at delivery was 34.6 weeks (IQR
31.3-35.6). All newborns were singleton and survived
until hospital discharge at a median age of 8 days of life
(IQR 5-47). None of the newborns developed E. coli bacteremia in either group
Antibiotics were administered within the first seven
days of life to 52 % of newborns born to noncolonized
women, whereas each newborn born to the colonized
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Table 1 Clinical Characteristic of women in preterm labor with or without E. coli colonization
All Subjects

Non-Colonized

Colonized

50

44 (88)

6 (12)

27
12
5
2
1
3

24
10
5
1
1
3

3
2
0
1
0
0

Race
• White
• Hispanic
• African-American
• American-Indian
• Asian
• Other
Median maternal age in years (25 %-75 %)

26.1 (23.3-30.1)

25.2 (22.5-29.9)

27.6 (25.5-32.7)

Mean GA at Sample Collection (±SD)

32.9 (2.91)

32.9 (2.99)

32.8 (2.23)

Median length of hospital stay in days (25 %-75 %)

3 (2-5.25)

3 (2-5.75)

2 (1-10)

Delivered

27 (54)

24 (54.5)

3 (50)

Presence of ROM

13 (26)

13 (29)

0

3 (6)
43 (86)
4 (8)

3 (7)
37 (84)
4 (9)

0
6 (100)
0

20 (40)
13 (26)
16 (32)
1 (2)

17 (38.6)
12 (27.3)
14 (31.9)
1 (2.2)

3 (50)
1 (16.7)
2 (33.3)
0

11 (22)
34 (68)
5 (10)

9 (20.5)
30 (68.2)
5 (11.3)

2 (33.3)
4 (66.6)
0

Chorioamnionitis
• Yes
• No
• Unknown
Nugent classification
• Normal
• Intermediate
• Bacterial vaginosis
• Invalid
GBS screening result
• Positive
• Negative
• Not performed
Legend: Data are presented as No. (%) unless otherwise indicated
GA, Gestational age in weeks; GBS, group B Streptococcus; ROM, Rupture of membranes; PTL, Pre-term Labor

mothers received antibiotics in the same period. The
median (25 %-75 %) length of stay in the hospital was
6.5 (3.2-42) days vs. 20 (3.5-33) days for the newborns
born to noncolonized vs. colonized women, respectively.
These differences were not statistically different likely due
to the small sample size
A detailed description of the clinical characteristics
of the 50 subjects included in the study can be found in
Additional file 1
Clinical microbiology laboratory data and genotypic
antibiotic resistance of E. coli cervical isolates

Phenotypic antibiotic susceptibility testing of E. coli
cervical isolates by the clinical microbiology laboratory
showed that most isolates were susceptible to all antibiotics tested by clinical standard methods. One isolate, SCBcol-5, was multi-drug resistant. None of the isolates met
the criteria for extensive drug resistance [12] (Table 2).
The K1 capsule was present in all isolates.
WGS data analyses to determine antibiotic resistance
genes were consistent with the phenotypic resistance

Table.2 Antibiotic susceptibility testing and presence of K1
capsule by agglutination test
E. coli Cervical
Isolate

Antibiotic Resistance

K1 capsule
agglutination
test

SCBcol-1a

• Ampicillin
• Ampicillin/sulbactam
• Piperacillin
• Tetracycline

Positive

SCBcol-2

None

Positive

SCBcol-3

• Tetracycline

Positive

SCBcol-4

• Tetracycline

Positive

SCBcol-5a

• Ampicillin
• Ampicillin/sulbactam
• Piperacillin
• Tetracycline
• TMP/SMX

Positive

SCBcol-6

None

Positive

Legend: TMP/SMX, Trimethoprim and sulfamethoxazole
a

Intermediate to cefazolin and ticarcillin/clavulanic acid
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Fig. 1 Presence of genes related to antibiotic resistance in cervical E. coli isolates from women in preterm labor. Legend: Whole genome
sequencing data was analyzed to determine the presence of antibiotic resistance genes using the ResFinder 4.0 database available from the Center
from Genomic Epidemiology as described in the Methods section. [13–15]. Shown are only genes that were present in at least one strain (black
cells). SCBcol-5, a multi-drug resistant isolate, showed the greatest number of antibiotic resistance genes

Table.3 Phylogroup and MLST classification of cervical E. coli
isolates colonizing women in preterm labor
Maternal Cervical E. coli
isolates

Phylogroup

Multi-locus
sequence
type

SCBcol-1

F

ST-31

SCBcol-2

E

ST-68

SCBcol-3

C

ST-1495

SCBcol-4

B1

ST-4252

SCBcol-5

B2

ST-131

SCBcol-6

B2

ST-491

Legend: Phylogroup assignment was performed by PCR methodology and
sequence type assignment was done by data analyses of WGS data as described
in the Methods section

patterns of these isolates as tested by the clinical microbiology laboratory. Accordingly, antibiotic resistance genes
were more prevalent in isolates SCBcol-1 and SCBcol-5
than in isolates SCBcol-2 and SCBcol-6 (Fig. 1).
Phylogenetic relatedness of cervical E. coli strains

Quadruplex PCR phylogroup classification demonstrated
that cervical E. coli isolates were distributed in diverse
phylogroups. Two isolates belonged to B2, a phylogroup
most commonly associated with neonatal E. coli bacteremia in the US and other countries (Table 3) [16–19]. One
cervical isolate belonged to phylogroup F, which is related
to phylogroup D, another phylogroup represented in isolates causing neonatal disease. Whole-genome sequencing (WGS)-based multi-locus sequence type (MLST)
classification revealed that the cervical E. coli isolates
were heterogeneous, and only one belonged to ST131, a
common sequence type (ST) found among neonatal invasive isolates in recent years.
The E. coli isolates colonizing the cervix of women
in PTL in our study were not associated with neonatal invasive disease in their offspring. This finding
prompted us to investigate the phylogenetic relationship of this group of cervical strains with representative

E. coli isolates commonly associated with neonatal
bacteremia. Very few studies in the United States have
described the genetic characteristics of invasive neonatal E. coli in newborns at the sequence type level. Our
recent work showed that ST95 and ST131 predominate among neonatal E. coli bacteremia isolates [20].
Weissman et al. similarly found ST95 to be the most
prevalent ST among invasive neonatal E. coli isolates,
followed by ST69 [21]. We, therefore, sought to compare the phylogenetic relationship of cervical colonizing E. coli strains with neonatal E. coli bacteremia
strains belonging to ST69 (isolates SCB5 and SCB29),
ST95 (SCB12 and RS218), and ST131 (isolates SCB34
and SCB58), which we have characterized in our laboratory [20, 22–24].
The archetypal ST95 neonatal invasive E. coli isolate RS218 was used as the reference sequence for constructing the maximum likelihood phylogenetic tree
shown in Fig. 2. This analysis showed close relatedness of SCBcol-1 to neonatal isolates SCB5 and SCB29.
Not surprisingly, SCBcol-5 (ST131) was closely related
to the neonatal isolates belonging to ST131, namely
SCB34 and SCB58. SCBcol-6 was most related to neonatal ST95 strains SCB12 and RS218. The colonizing
strains least related to neonatal strains were SCBcol-2,
SCBcol-3, and SCBcol-4. These results demonstrate
that E. coli isolates capable of colonizing the cervix of
pregnant women are heterogeneous, and as a group,
not fully phylogenetically representative of E. coli
strains commonly causing neonatal invasive disease.
To further examine differences in the full complement of genes among cervical and neonatal E. coli
strains, we performed a pangenome analysis using the
Gview server and its genome visualization tool. E. coli
RS218 was used as the seed genome and the complete
genomes of all cervical and neonatal isolates were
added to generate the circular representation shown
in Fig. 3. This graphic representation is constructed by
using the Basic Local Alignment Search Tool (BLAST)
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Fig. 2 Single nucleotide polymorphism (SNP)-based phylogenetic tree comparing cervical E. coli isolates and representative neonatal E. coli
bacteremia strains. Legend: WGS data was used to perform phylogenetic comparisons of E. coli cervical colonization isolates with neonatal
bacteremia isolates. Data were analyzed with CSI Phylogeny 1.4 and a tree was constructed to show the relatedness among neonatal and cervical
isolates [25] The SNP-based tree shows that the colonizing strain SCBcol-5 was the closest related to the neonatal bacteremia isolates SCB34 and
SCB58, all belonging to the same ST131. The least related cervical colonization isolates in relation to neonatal isolates were SCBcol-2, SCBcol-3, and
SCBcol-4

to compare the reference sequence with the WGS data
of each additional isolate by constructing a reference
pangenome, and the results are included on the map
[26]. All the sequences, including the RS218 (reference)
sequence were uploaded in GenBank format, therefore
allowing feature information to be extracted and comparisons generated in a tabular format as well (Additional file 2).
Pangenome comparisons demonstrated that > 50 % of
genes present in neonatal invasive isolates were shared
with maternal strains, especially those in SCB5 and
SCB29. However, there were genes present only in some
neonatal strains, and among them, we identified ibeA in
strains RS218 and SCB12 (Fig. 3B) (Additional file 2).
This gene encodes the invasion of brain endothelium
A (IbeA) protein that contributes to the development
of meningitis by neonatal E. coli strains [27–29]. Genes
encoding for the siderophore salmochelin, iroBCDEN,
(Fig. 3 C) were also only present in RS218 and SCB12.
The complete list of gene content comparisons among all
strains is included in Additional file 2.
Figure 3 also shows several genomic regions specific
to individual cervical isolates absent in neonatal isolates
and that were shared only with partial regions of other

cervical isolates. These regions include genes encoding
several hypothetical proteins, fimbrial proteins, secretion
system components, and membrane proteins, among
others (Additional file 2). Taken together, our findings
indicate an overall richer genome diversity of colonizing cervical strains compared to invasive neonatal E. coli
strains.
Epithelial invasion by maternal and neonatal E. coli strains

The invasive ability of maternal cervical E. coli isolates was assessed using an epithelial invasion in vitro
model using intestinal T84 cells. The percent invasion
of each isolate varied from 0.02 % (SD±0.007) to 1.16 %
(SD±0.44) (Additional file 3). Given the phylogenetic
similarities of cervical isolates SCBcol-1, SCBcol-5, and
SCBcol-6 with the selected neonatal invasive isolates
(Fig. 2), we compared their epithelial invasion capacity as
a group with the invasion ability of the group of neonatal
strains included in the study. As demonstrated in Fig. 4,
in vitro invasiveness of SCBcol-1, SCBcol-5, and SCBcol-6 was comparable to that of neonatal isolates. On the
other hand, the group of cervical isolates that were most
distantly phylogenetically related at the phylogenetic
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level, i.e., SCBcol-2, SCBcol-3, and SCBcol-4, had significantly lower invasion capacity (p<0.03).

Discussion
The purpose of our pilot study was to investigate the
presence of E. coli colonizing the cervix of women diagnosed with PTL. Our objective was to better understand
the phylogeny, antibiotic resistance traits, and invasive
properties of the E. coli strains recovered in this relevant
clinical scenario. We focused on colonization of the cervix, the highest anatomical site in the genital tract that
can be accessed by clinical examination in a non-invasive
manner and is the location of colonizing microorganisms
with the potential to access the amniotic cavity and infect
the newborn.
Our sample cohort demonstrated a prevalence of E.
coli cervical colonization of 12 % (95 % CI 2.99-21.01).
Several studies have reported a variable rate of carriage
of E. coli in vaginal samples from pregnant women
(from 12 % to 19 % in North and South America and
Europe). Still, data on cervical colonization are scarce,
particularly in recent years [31]. A study in Europe documented a similar prevalence of E. coli of 14 % in cervical samples of women in PTL [32]. On the other hand,
endocervical colonization rates were lower at 3.5 %
among women in labor in Switzerland [33] and higher
at 24 % in Iranian women with premature preterm rupture of membranes ROM [34]. Our pilot study provides
initial information on the prevalence of E. coli cervical colonization in US women in PTL. Our study was
descriptive and was not powered to establish whether
E. coli cervical colonization was a risk for neonatal sepsis in our population. Because of very small sample size,
we did not find statistical differences between groups
regarding race distribution, maternal chronological age,
gestational age, and length of hospital stay between the
groups of colonized vs. noncolonized women. Likewise, differences in neonatal clinical outcomes cannot
be determined from this study. Additional studies
are needed to define the risk of vertical transmission
of E. coli from colonized mothers to their newborns
in relation to various clinical variables, including the
possible role that the amount of E. coli colonization
may play on clinical outcomes. Larger studies will aid
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to determine the most effective screening strategies in
pregnant women that would inform potential preventative measures against neonatal E. coli sepsis.
We did not find evidence of widespread multi-drug
resistance among the cervical E. coli isolates that we
recovered in this population of women in PTL. Data
on antibiotic resistance of E. coli isolates colonizing the
genital tract of pregnant women are limited and vary
according to geographic location. Widespread resistance
to beta-lactam antibiotics in E. coli is an increasing concern. Prevalence of extended-spectrum beta-lactamases
(ESBL)-producing E. coli colonizing pregnant women has
been reported between 2 and 7 % in South Asia, Europe,
Africa, and Japan [35–39], and as high as 15-40 % in India
[10, 40]. It is possible that we did not find extensively
resistant or ESBL-producing E. coli strains in our study
because we excluded pregnant women with a recent history of antibiotic use, which increases the risk of colonization with resistant organisms [10]. However, one of the
cervical isolates, which belonged to ST131 demonstrated
MDR. This clonal group is frequently associated to antibiotic resistance and can be found in asymptomatic pregnant women [41]. Larger studies are needed to determine
the rates of resistance in E. coli colonizing pregnant
women over time more accurately. Our study included
detailed characterization of the genetic determinants of
antibiotic resistance in the colonizing strains we recovered along with corresponding phenotypic resistance
data. Our findings are in concordance with previous
studies demonstrating that genotypic susceptibility testing can be as reliable as phenotypic testing [13]. Ongoing
surveillance of antibiotic resistance in E. coli strains that
colonize pregnant women is crucial, as this may impact
treatment decisions for antimicrobial therapy. While
antibiotic resistance in neonatal E. coli invasive is not
widespread in the US yet, worrisome trends have already
emerged that warrant close monitoring [42, 43].
The phylogeny of E. coli isolates colonizing the genital
tract of pregnant women has not been explored in detail.
Our phylogenetic analyses showed that half of the cervical strains belonged to phylogroups typically associated
with severe invasive E. coli infections, including neonatal
sepsis, i.e., phylogroup B2, and the related phylogroup F
[44, 45]. We also demonstrated colonization with strains

(See figure on next page.)
Fig. 3 Visualization of pangenome analysis comparing cervical colonizing E. coli isolates with representative neonatal E. coli invasive strains. Legend:
A is a circular representation of all isolates included in the analyses. The innermost circle represents the position of all features on the pangenome.
Rings 2 and 3 show the GC skew and content, respectively. Ring 4 represents the pangenome, separated by a black ring from the reference RS218
sequence (ring 6), and the sequences of all additional isolates (rings 7-17). B C are linear representations of the above comparisons. Figure 3B
highlights the location of the ibeA gene, which is relevant to the pathogenesis of neonatal meningitis [27–29]. C shows the presence of the
iroBCDEN genes relevant to the synthesis and processing of salmochelin, a siderophore involved in the pathogenesis of invasive E. coli infections
[30]. The location of these specific genes is indicated by a black oval in B C
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Fig. 4 Epithelial invasion comparisons of cervical colonization and invasive neonatal E. coli isolates. Legend: The invasion capacity of E. coli cervical
isolates and neonatal bacteremia isolates was compared using an intestinal epithelial cell invasion model in-vitro [23]. Cervical colonization isolates
most closely related to neonatal bacteremia isolates at the phylogenetic level (SCBcol-1, SCBcol-5, and SCBcol-6) showed the greatest invasion
capacity as a group, as compared to the group of least phylogenetically related colonization isolates (P<0.03, one way ANOVA)

classified in phylogroups B1, C and E, which more commonly behave as commensals [46]. Other studies from
Spain and Japan have reported a prevalence of phylogroup B2 of 60 %-70 % among vaginal and endocervical
E. coli isolates from pregnant women [47, 48]. In Africa,
however, vaginal isolates from pregnant women belonged
predominantly to the traditionally less pathogenic phylogenetic groups A and E [49]. Possible explanations of
these differences may include the diverse anatomic locations for sample collection, geographic factors, and the
pregnancy stage and obstetric complications of subjects
included in the various studies.
Our study included MLST, a more refined method to
study E. coli phylogeny [50]. MLST analyses showed that
the colonizing isolate SCBcol-5 belonged to ST-131, an
ST commonly found among invasive neonatal E. coli isolates in the US. Two other colonizing isolates were also
phylogenetically similar to E. coli STs associated with
invasive infections in newborns [20, 21]. Moreover, we
demonstrated that these related cervical isolates had a
significantly greater ability to invade epithelial cells than
the more phylogenetically distant cervical strains. Despite
the observed phylogenetic and phenotypic characteristics, none of the cervical isolates were associated with
invasive disease in the offspring of the colonized mothers

in our study. This is most likely related to the overall low
rates of neonatal sepsis in the United States. Other possible explanations include gestational age beyond the
threshold of extreme prematurity, and the lack of other
risk factors such as premature rupture of membranes
or chorioamnionitis. Another possible explanation is
the lack of virulence genes specific to the pathogenesis
of neonatal sepsis in the cervical E. coli strains we isolated. As demonstrated by our Gview comparisons, genes
known to be relevant to E. coli invasive infections such
as those encoding IbeA and siderophore-related proteins
were only present in neonatal invasive isolates and not in
any cervical strains. Interestingly, all the cervical strains
showed the presence of the K1 antigen, a virulence factor known to be present in approximately 80 % of E. coli
isolates causing neonatal meningitis, and about 50 % of E.
coli strains causing neonatal sepsis [20, 21, 51, 52]. While
it has been well established that the K1 capsule facilitates
E. coli survival in the blood and modulates bacterial trafficking and enhances survival in brain microvascular
endothelial cells [53], its role as a risk factor for maternalchild transmission is not defined. The entire repertoire of
E. coli virulence factors involved in the pathogenesis of
neonatal E. coli invasive infections has not been defined.
As such, it may be possible that among the genes present
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only in neonatal strains that were isolated, are those
important in the pathogenesis of neonatal E. coli sepsis
(Additional file 2). We also demonstrated that the cervical E. coli strains carried genes that were not present in
the neonatal invasive strains. We speculate that these
genes may confer a better ability to colonize without necessarily causing invasive disease.
The limitations of our study include a very small number of subjects and its single-center setting. However, its
prospective design strengthens the results of this pilot
study that addresses the scarcity of data on the rates of E.
coli in the genital tract of pregnant women, particularly
in the United States. Moreover, we focused on women in
PTL, a population with the potential for delivering a preterm newborn at high risk for invasive E. coli disease and
in whom the significance of maternal E. coli colonization
needs further definition. Our study also contributes with
new data on the molecular characteristics of E. coli colonizing pregnant women that determine their phylogeny
and influence their phenotypic antibiotic resistance patterns and invasiveness potential.

antibiotic therapy within 2 weeks prior to enrollment,
history of genitourinary abnormalities, history of pelvic
surgery or cervical cerclage, use of tocolytics or steroids during the current pregnancy, and human immunodeficiency virus infection. Demographic and clinical
data were collected, including pregnancy complications,
and neonatal outcomes. Data were collected for pregnant women through discharge, newborns’ charts were
reviewed through discharge and for up to three months
after birth for any return visits to our medical system.
Cases of chorioamnionitis were assigned if included
in the physicians’ diagnoses list at any point during the
admission, or if confirmed by placental histopathologic examination. Chorioamnionitis was classified as
unknown if data were not collected from the medical
record. The obstetricians providing standard of care to
the women included in the study were not made aware
of whether a woman was carrying E. coli once results
became available.

Conclusions
This study provides much needed information on relevant characteristics of the cervical E. coli strains that
colonize pregnant women at risk for delivering a preterm
infant in whom the susceptibility to infection is high.
The pilot nature of this project with very limited sample size does not allow generalization to larger populations. Additional studies will aim at further defining the
prevalence and the characteristics of the E. coli strains
that colonize the genital tract of pregnant women. This
information is essential to design appropriate preventive
strategies against neonatal E. coli sepsis, which currently
do not exist.

The obstetric standard of care for women in PTL at
OUHSC includes a vaginal/cervical examination using a
sterile speculum to obtain microbiology samples, and to
evaluate for possible cervical dilatation, and to ascertain
whether rupture of amniotic membranes has occurred
[55]. For our study, two additional swab samples were
collected at the time of the routine speculum examination on the day of hospital admission. One sterile swab
was used to sample the cervix (avoiding the cervical
canal) to test for E. coli, and a second swab was used to
sample the mid-third of the vagina to prepare a slide for
determination of bacterial vaginosis (BV) using a formal
scoring system assigned by a pathologist (CBM). The
swabs were kept at 4 °C until transported to the clinical
laboratory, which occurred within 2 h of collection.

Methods
This was a prospective, pilot study aimed at investigating
the E. coli colonization rate, and the phylogeny, antibiotic
resistance traits, and invasive properties of E. coli strains
isolated from the cervix of women diagnosed with preterm labor (PTL).
Patient population

This was a prospective study performed at the University of Oklahoma Medical Center (OUHSC), from March
2014 to December 2015. Women >18 years old diagnosed
with preterm labor (PTL) between 23 and <37 weeks of
gestation from the last menstrual period were eligible for
enrollment. Preterm labor was defined as the presence
of regular uterine contractions and documented cervical
effacement and/or dilatation of at least 2 cm in patients at
<37 weeks of gestation [54]. Exclusion criteria included

Cervical sample collection

Clinical laboratory processing

Cervical samples were inoculated onto blood and
MacConkey agar plates and into MacConkey broth for
enrichment of Gram-negative organisms. Broth was
plated to a MacConkey agar plate after 24 h incubation.
E. coli colonies were selected based on growth/lactose
fermentation on MacConkey, indole positivity, and oxidase negativity. E. coli identification was confirmed using
the MicroScan Negative Urine Combo 61 (NUC61) panel
on the MicroScan WalkAway plus System (Siemens Corporation). Phenotypic antibiotic susceptibility testing was
determined using both the MicroScan NUC61 panel,
which included determination of extended spectrum
beta lactamase-producing isolates, and the TREK Sensititre GN4F Gram negative MIC Plate (TREK Diagnostic
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Systems/Thermo Scientific). Antibiotics used for susceptibility testing are listed in Additional File 4. The isolates
were also tested for the presence of the K1 capsule with
a card latex agglutination test (Wellcogen, Remel Europe
Ltd, Dartford, Kent, UK). A single colony of an overnight
plate culture of each isolate was tested with the appropriate positive and negative controls according to the manufacturer’s protocol.
The vaginal swab was used to prepare a smear on a
glass slide that was heat fixed and Gram stained for
determination of BV using the Nugent score [56]. BV
scoring was determined by a pathologist (CBM) who was
blinded to other study results. This method classified the
samples into four categories: Normal, intermediate, bacterial vaginosis, and indeterminate.
Bacterial genotypic analyses for antibiotic susceptibility
testing and phylogenetic relatedness

Bacterial genomic DNA from each E. coli isolate was
purified with the Qiagen® DNeasy extraction kit. Phylogroup classification was performed with the Clermont
quadruplex polymerase chain reaction method using the
primers and conditions described earlier [20]. WGS was
performed with Illumina HiSeq technology using 250bp paired-end libraries with 50X coverage. Reads were
assembled de novo with the A5 assembler pipeline [57].
Contigs were analyzed using the bioinformatics resources
available at the Centre of Genomic Epidemiology (CGE)
from the Technical University of Denmark (http://www.
genomicepidemiology.org/). ResFinder 4.0 was used for
genotypic detection of antibiotic resistance including all
the available acquired antimicrobial resistance genes in
the database. Default threshold for percent identity of
90 %, and minimum length of 60 % were chosen [13, 14].
MLST 2.0 (E. coli configuration #1) was used to assign
the ST of each strain according to the Achtman scheme
[58, 59]. CSI Phylogeny 1.4. from CGE was used to determine the phylogenetic relatedness among the strains
based on the concatenated alignment of high quality
single nucleotide polymorphisms (SNPs) [25]. The neonatal invasive E. coli isolate RS218 was used as the reference genome [24]. Default parameters were used, and
a phylogenetic tree was generated selecting the FastTree
option. The WGS interactive visualization tool GView
was used to perform comparative genome analyses of
all isolates [26, 60]. A pangenome reference was created
using RS218 as the seed genome and sequentially adding
all genomes of cervical and neonatal E. coli isolates. This
pangenome was then used to compare each individual
E. coli genome to the pangenome using a BLAST atlas.
Default settings on Gview were used, including an identity percent cutoff of 80 %. Circular representations were
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generated and tabular results of BLASTn comparisons
were downloaded in .xls format.
Comparisons of invasion capabilities among maternal
cervical colonizing E. coli and neonatal invasive E. coli
isolates

A modified gentamicin protection assay was used to
determine the E. coli isolates’ ability to invade intestinal epithelial cells as described before [23]. Briefly, T84
intestinal epithelial cell monolayers were infected with
each E. coli strain at a multiplicity of infection of 10.
Bacteria were allowed to invade for 1 h before washing,
followed by the addition of amikacin at a concentration
of 200 µg/mL (Sigma-Aldrich; St. Louis, MO) for two
additional hours to kill extracellular bacteria. All isolates were verified to be susceptible to amikacin with a
minimum inhibitory concentration of ≤ 16 µg/mL. After
antibiotic treatment, the T84 cells were washed, lysed
with 0.1 % Triton X-100, and the recovered intracellular
bacteria were quantified. The percent invasion was calculated as follows: (CFU recovered/CFU inoculated) x
100. Each isolate was tested in triplicate and experiments
were repeated two to four times. Mean invasion percent
was compared among the strains using one-way ANOVA
comparisons; a p value <0.05 was considered significant.
Statistical methods

Descriptive statistics were used to analyze parametric
and nonparametric data, as appropriate. The Fisher exact
test was used to compare proportions, and the Student’s
t-test or ANOVA were used to compare continuous data.
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